Westminster Health Forum

We are continuing to organise full-scale virtual conferences which retain all the features of physical seminars, including full programmes, presentations with slides, panel discussions and live delegate questions and comments sessions, person-to-person and group networking, and a permanent record provided to all delegates afterwards. New events are coming on to our conference programme all the time, so there are plenty of opportunities to join us if you haven’t already, from wherever you are.
For booking-related queries or information on speaking please email us at info@forumsupport.co.uk, or contact us using one of the following numbers: +44 (0)7538736244 / +44 (0)7503591880 / +44 (0)7951044809.

If you’re already booked on, joining instructions can be accessed from five working days before your conference via the booking dashboard. Need help? Contact us at delegate.relations@forumsupport.co.uk

Priorities for cancer care - service restoration and transformation, supporting innovation, and opportunities for improving patient outcomes

Morning, Thursday, 30th September 2021

***Full-scale policy conference taking place online***

This conference will examine the priorities outlined in the Cancer Services Recovery Plan and how best to support cancer care and diagnosis - as well as priorities for the Cancer Drugs Fund and innovation going forward.

It will be an opportunity to discuss how NHS reform can support long-term ambitions for cancer, with the Government’s Health and Care Bill aiming to support the integration of health and care in local areas, and build upon innovative developments from the pandemic in order to drive forward the delivery of the NHS Long Term Plan.

The discussion also takes place following the publication of The Forgotten C: The Impact of COVID-19 on Cancer Patients from Macmillan Cancer Support, which outlines concerns over the backlog resulting from the pandemic, with several recommendations for Government.

We are delighted to be able to include keynote addresses from Professor Peter Clark, Clinical Lead for the Cancer Drugs Fund, NHS England; Professor Anne Mackie, Director of Screening, Public Health England; Dr Ian McKay, Innovation Lead for Advanced Therapies, Innovation UK; and Amanda Pleavin, Managing Director, East of England Cancer Alliances and COVID-19 Cancer Recovery Lead, NHS England and NHS Improvement - East of England.

The agenda will bring out latest thinking on:

  • priorities for service restoration - assessing priorities, plans, and progress, as well looking at the impact the pandemic on the range of aspects of cancer diagnosis, treatment, and care
  • NHS reforms - the role of reform in cancer service delivery, and priorities for the Cancer Recovery Programme and the NHS Long Term Plan
  • funding and investment - assessing the current landscape for funding, and priorities for the Cancer Drugs Fund
  • innovation - next steps for developments in medicine and technology for cancer treatment and improving patient outcomes


Our forums are known for attracting strong interest from policymakers and stakeholders. Places have been reserved by officials from the Department of Health, NI; the Department of International Trade; and the Medicines and Healthcare products Regulatory Agency. Also due to attend are representatives from B. Braun Medical; Boehringer Ingelheim; Eli Lilly; GlaxoSmithKline; Guardant Health; Healthwatch Worcestershire; Incisive Health; IPATHDIGITAL Community Interest Company; Macmillan Cancer Support; NHS Wales Collaborative Northumbria Healthcare; Pierre Fabre; Public Health England; Public Health Scotland; Roche; Sanofi UK; and Society of Radiographers.

Overall, we expect speakers and attendees to be a senior and informed group including Members of both Houses of Parliament, senior government and regulatory officials involved in this area of policy, as well as from representatives from the NHS, executive agencies including clinical staff, regulators, local authorities, the independent and third sectors, patient groups, pharmaceutical companies, research and development, law firms, consultancies, and others affected by the issues discussed as well as academics and think tanks, together with reporters from the national and specialist media.

This is a full-scale conference taking place online***

  • full, four-hour programme including comfort breaks - you’ll also get a full recording and transcript to refer back to
  • information-rich discussion involving key policymakers and stakeholders
  • conference materials provided in advance, including speaker biographies
  • speakers presenting via webcam, accompanied by slides if they wish, using the Cisco WebEx professional online conference platform (easy for delegates - we’ll provide full details)
  • opportunities for live delegate questions and comments with all speakers
  • a recording of the addresses, all slides cleared by speakers, and further materials, is made available to all delegates afterwards as a permanent record of the proceedings
  • delegates are able to add their own written comments and articles following the conference, to be distributed to all attendees and more widely
  • networking too - there will be opportunities for delegates to e-meet and interact - we’ll tell you how!

Full information and guidance on how to take part will be sent to delegates before the conference

Keynote Speakers

Amanda Pleavin

Managing Director, East of England Cancer Alliances and COVID-19 Cancer Recovery Lead, NHS England and NHS Improvement - East of England

Professor Anne Mackie

Director of Screening, Public Health England

Dr Ian McKay

Innovation Lead for Advanced Therapies, Innovation UK


Tim Farron MP

Chair, All-Party Parliamentary Group for Radiotherapy

Rt Hon the Lord Lansley

Former Secretary of State for Health


Dr Angela George

Consultant Medical Oncologist and Clinical Director of Genomics, the Royal Marsden Hospital

Dr Jeanette Dickson

President, The Royal College of Radiologists

Dr Abhijit Gill

GP, Acute Diagnostic Oncology Clinic, Chelsea and Westminster Hospital NHS Foundation Trust

Professor Peter Clark

Clinical Lead for the Cancer Drugs Fund, NHS England

Ali Stunt

Chief Executive Officer, Pancreatic Cancer Action

Dr Neville Young

Director of Enterprise and Innovation, Yorkshire and Humber Health Education

Suzanne Wait

Managing Director, Health Policy Partnership